{"id":"https://openalex.org/W4401965646","doi":"https://doi.org/10.2174/0118715206318833240819031953","title":"A Promising Paradigm Shift in Cancer Treatment with FGFR Inhibitors","display_name":"A Promising Paradigm Shift in Cancer Treatment with FGFR Inhibitors","publication_year":2024,"publication_date":"2024-08-28","ids":{"openalex":"https://openalex.org/W4401965646","doi":"https://doi.org/10.2174/0118715206318833240819031953","pmid":"https://pubmed.ncbi.nlm.nih.gov/39192641"},"language":"en","primary_location":{"id":"doi:10.2174/0118715206318833240819031953","doi":"https://doi.org/10.2174/0118715206318833240819031953","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0118715206318833240819031953","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100780761","display_name":"Anuradha Mehra","orcid":"https://orcid.org/0000-0002-7405-8809","observed_orcids":["https://orcid.org/0000-0002-7405-8809"]},"institutions":[{"id":"https://openalex.org/I110360157","display_name":"Lovely Professional University","ror":"https://ror.org/00et6q107","country_code":"IN","type":"education","lineage":["https://openalex.org/I110360157"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anuradha Mehra","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T.\nRoad (NH-1), Phagwara (Punjab), 144411, India"],"raw_orcid":"https://orcid.org/0000-0002-7405-8809","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T.\nRoad (NH-1), Phagwara (Punjab), 144411, India","institution_ids":["https://openalex.org/I110360157"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040368303","display_name":"Rekha Sangwan","orcid":"https://orcid.org/0000-0002-0106-4319","observed_orcids":["https://orcid.org/0000-0002-0106-4319"]},"institutions":[{"id":"https://openalex.org/I110360157","display_name":"Lovely Professional University","ror":"https://ror.org/00et6q107","country_code":"IN","type":"education","lineage":["https://openalex.org/I110360157"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Rekha Sangwan","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T.\nRoad (NH-1), Phagwara (Punjab), 144411, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T.\nRoad (NH-1), Phagwara (Punjab), 144411, India","institution_ids":["https://openalex.org/I110360157"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040368303"],"corresponding_institution_ids":["https://openalex.org/I110360157"],"apc_list":null,"apc_paid":null,"fwci":0.2848,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.27899301,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"25","issue":"1","first_page":"2","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.9010000228881836},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7110000252723694},{"id":"https://openalex.org/keywords/anticancer-drug-development","display_name":"anticancer drug development","score":0.6119999885559082},{"id":"https://openalex.org/keywords/naphthyl-derivatives","display_name":"naphthyl derivatives","score":0.8450000286102295},{"id":"https://openalex.org/keywords/pyrimidine-derivatives","display_name":"pyrimidine derivatives","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pyridazine-derivatives","display_name":"pyridazine derivatives","score":0.9929999709129333},{"id":"https://openalex.org/keywords/indole-derivatives","display_name":"indole derivatives","score":1.0},{"id":"https://openalex.org/keywords/quinoline-derivatives","display_name":"quinoline derivatives","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.6370000243186951},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.7705288529396057},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.5713703036308289},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.46790608763694763},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4381812810897827},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4234713017940521},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4002918601036072},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3767639696598053},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3109082579612732},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30241402983665466},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2906854748725891},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.21001803874969482},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15592792630195618},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13962095975875854},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017468","descriptor_name":"Receptors, Fibroblast Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017468","descriptor_name":"Receptors, Fibroblast Growth Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/0118715206318833240819031953","doi":"https://doi.org/10.2174/0118715206318833240819031953","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0118715206318833240819031953","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:39192641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39192641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":93,"referenced_works":["https://openalex.org/W1765107706","https://openalex.org/W1891334654","https://openalex.org/W1960850967","https://openalex.org/W1965358479","https://openalex.org/W1965727465","https://openalex.org/W1971340381","https://openalex.org/W1973430254","https://openalex.org/W1982887112","https://openalex.org/W1983790923","https://openalex.org/W1988476050","https://openalex.org/W1989221709","https://openalex.org/W1992388470","https://openalex.org/W1998338586","https://openalex.org/W2015786768","https://openalex.org/W2017722766","https://openalex.org/W2019711215","https://openalex.org/W2020956724","https://openalex.org/W2027215055","https://openalex.org/W2027239974","https://openalex.org/W2031597668","https://openalex.org/W2034428792","https://openalex.org/W2050244095","https://openalex.org/W2056983875","https://openalex.org/W2064466696","https://openalex.org/W2068549807","https://openalex.org/W2071500926","https://openalex.org/W2072737626","https://openalex.org/W2078054478","https://openalex.org/W2079369305","https://openalex.org/W2080626878","https://openalex.org/W2088872576","https://openalex.org/W2093090488","https://openalex.org/W2094141392","https://openalex.org/W2095888060","https://openalex.org/W2096861064","https://openalex.org/W2096950509","https://openalex.org/W2098178673","https://openalex.org/W2098466520","https://openalex.org/W2100374586","https://openalex.org/W2101844536","https://openalex.org/W2116368558","https://openalex.org/W2136977400","https://openalex.org/W2138178479","https://openalex.org/W2139046059","https://openalex.org/W2141125422","https://openalex.org/W2161608625","https://openalex.org/W2161730969","https://openalex.org/W2175330263","https://openalex.org/W2308989383","https://openalex.org/W2340909673","https://openalex.org/W2474854223","https://openalex.org/W2548465807","https://openalex.org/W2549346602","https://openalex.org/W2550856922","https://openalex.org/W2554912881","https://openalex.org/W2566505805","https://openalex.org/W2600903921","https://openalex.org/W2804029286","https://openalex.org/W2900605906","https://openalex.org/W2909160537","https://openalex.org/W2912013265","https://openalex.org/W2915838327","https://openalex.org/W2928704395","https://openalex.org/W2948387511","https://openalex.org/W2963788129","https://openalex.org/W2964244478","https://openalex.org/W3006012565","https://openalex.org/W3032673000","https://openalex.org/W3037014259","https://openalex.org/W3082979654","https://openalex.org/W3097439385","https://openalex.org/W3126339282","https://openalex.org/W3157978547","https://openalex.org/W3168947449","https://openalex.org/W3179104071","https://openalex.org/W3186228217","https://openalex.org/W3194819363","https://openalex.org/W3203133679","https://openalex.org/W4210683919","https://openalex.org/W4220916720","https://openalex.org/W4220960602","https://openalex.org/W4280631229","https://openalex.org/W4281705510","https://openalex.org/W4285084426","https://openalex.org/W4295867447","https://openalex.org/W4307178968","https://openalex.org/W4308698174","https://openalex.org/W4310117868","https://openalex.org/W4310552715","https://openalex.org/W4310941128","https://openalex.org/W4321367496","https://openalex.org/W4377693783","https://openalex.org/W4399290623"],"related_works":["https://openalex.org/W2885475927","https://openalex.org/W4310431370","https://openalex.org/W2982968798","https://openalex.org/W3157978547","https://openalex.org/W7125396197","https://openalex.org/W4399466532","https://openalex.org/W2567504270","https://openalex.org/W4414062936","https://openalex.org/W4414079308","https://openalex.org/W2606397339"],"abstract_inverted_index":{"FGFR":[0,39,50,69,94,121,134],"have":[1,41,77,98],"been":[2,16,78],"demonstrated":[3],"to":[4,59,81,90,100,151],"perform":[5],"a":[6,142],"crucial":[7],"role":[8],"in":[9,22,123,156],"biological":[10],"processes":[11],"but":[12],"their":[13],"overexpression":[14],"has":[15],"perceived":[17],"as":[18,106],"the":[19,23,35,45,55,73,116,130,148],"operator":[20],"component":[21],"occurrence":[24],"and":[25,65,84,111,118],"progression":[26],"of":[27,30,33,54,120,133],"different":[28,86],"types":[29],"carcinoma.":[31],"Out":[32],"all":[34],"interest":[36],"around":[37],"cancer,":[38],"inhibitors":[40,51,70,122,135],"assembled":[42],"pace":[43],"over":[44],"past":[46],"few":[47],"years.":[48],"Therefore,":[49],"are":[52,71],"one":[53],"main":[56],"fundamental":[57],"tools":[58],"reverse":[60],"drug":[61],"resistance,":[62],"tumor":[63],"growth,":[64],"angiogenesis.":[66],"Currently,":[67],"many":[68],"under":[72],"development":[74],"stage":[75],"or":[76],"developed.":[79],"Due":[80],"great":[82,143],"demand":[83],"hotspots,":[85],"pharmacophores":[87],"were":[88],"approached":[89],"access":[91],"structurally":[92],"diverse":[93],"inhibitors.":[95],"Here,":[96],"we":[97],"selected":[99],"present":[101],"several":[102],"representative":[103],"examples":[104],"such":[105],"Naphthyl,":[107],"Pyrimidine,":[108],"Pyridazine,":[109],"Indole,":[110],"Quinoline":[112],"derivatives":[113],"that":[114,146],"illustrate":[115],"diversity":[117],"advances":[119],"medicinal":[124,149],"chemistry.":[125],"This":[126],"review":[127],"focuses":[128],"on":[129],"SAR":[131],"study":[132],"last":[136],"five":[137],"years":[138],"which":[139],"will":[140],"be":[141],"future":[144],"scope":[145],"influences":[147],"chemist":[150],"work":[152],"towards":[153],"more":[154],"achievements":[155],"this":[157],"area.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-08-29T00:00:00"}